MANIPULATING THE DOPAMINERGIC SYSTEM IN PARKINSONS-DISEASE

被引：6

作者：

LANG, AE

机构：

来源：

PHARMACOLOGY & THERAPEUTICS | 1987年 / 32卷 / 01期

关键词：

D O I：

10.1016/0163-7258(87)90063-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：51 / 76

页数：26

共 203 条

[1] BRAIN PEROXIDASE AND CATALASE IN PARKINSON DISEASE [J].

AMBANI, LM ;

VANWOERT, MH ;

MURPHY, S .

ARCHIVES OF NEUROLOGY, 1975, 32 (02) :114-118

[2] LONG-TERM L-DOPA PRETREATMENT OF MICE - CENTRAL RECEPTOR SUBSENSITIVITY OR SUPER-SENSITIVITY [J].

BAILEY, RC ;

JACKSON, DM ;

BRACS, PU .

PSYCHOPHARMACOLOGY, 1979, 66 (01) :55-61

[3] PERMANENT HUMAN PARKINSONISM DUE TO 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) - 7 CASES [J].

BALLARD, PA ;

TETRUD, JW ;

LANGSTON, JW .

NEUROLOGY, 1985, 35 (07) :949-956

[4]

BANNON MJ, 1981, MOL PHARMACOL, V19, P270

[5] ETIOLOGY OF PARKINSONS-DISEASE - A RESEARCH STRATEGY [J].

BARBEAU, A .

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) :24-28

[6]

BARBEAU A, 1975, LANCET, V1, P756

[7]

BARBEAU A, 1985, ANN NEUROL, V18, P138

[8]

BARBEAU A, 1985, LANCET, V2, P1213

[9]

BARBEAU A, 1969, CAN MED ASSOC J, V101, P659

[10]

BARBEAU A, 1979, ADV NEUROL, V24, P433

← 1 2 3 4 5 6 7 8 9 10 →